Loading...
Evaluation of 0.2 µg/day fluocinolone acetonide (ILUVIEN) implant in a cohort of previously treated patients with diabetic macular oedema (DMO): a 36-month follow-up clinical case series
OBJECTIVE: To assess the real-world effectiveness and safety of single injection of a fluocinolone acetonide (FAc) implant in previously treated patients with recurrent diabetic macular oedema (DMO) over a 36-month follow-up period. METHODS AND ANALYSIS: This is a retrospective study conducted at a...
Na minha lista:
| Udgivet i: | BMJ Open Ophthalmol |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BMJ Publishing Group
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7337879/ https://ncbi.nlm.nih.gov/pubmed/32656358 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjophth-2020-000484 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|